Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stijn van Roessel

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 22, 2021
Preoperative misdiagnosis of pancreatic and periampullary cancer in patients undergoing pancreatoduodenectomy: A multicentre retrospective cohort studyStijn van Roessel, Eline C Soer, Lois A Daamen, et al.
Journal of Surgical Oncology|June 11, 2021
Predicting overall survival and resection in patients with locally advanced pancreatic cancer treated with FOLFIRINOX: Development and internal validation of two nomogramsLilly J H Brada, Marieke S Walma, Lois A Daamen, et al.
The British Journal of Surgery|November 18, 2021
Venous wedge and segment resection during pancreatoduodenectomy for pancreatic cancer: impact on short- and long-term outcomes in a nationwide cohort analysisJesse V Groen, Nynke Michiels, Stijn van Roessel, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 12, 2020
Amsterdam International Consensus Meeting: tumor response scoring in the pathology assessment of resected pancreatic cancer after neoadjuvant therapyBoris V Janssen, Faik Tutucu, Stijn van Roessel, et al.
The British Journal of Surgery|July 13, 2023
Predictive value of baseline serum carbohydrate antigen 19-9 level on treatment effect of neoadjuvant chemoradiotherapy in patients with resectable and borderline resectable pancreatic cancer in two randomized trialsDeesje Doppenberg, Jacob L van Dam, Youngmin Han, et al.
Annals of Surgery|January 31, 2025
Validation of the PANAMA Score for Survival and Benefit of Adjuvant Therapy in Patients With Resected Pancreatic Cancer after Neoadjuvant FOLFIRINOXIngmar F Rompen, Thomas F Stoop, Stijn van Roessel, et al.
JAMA Oncology|September 10, 2020
Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX TreatmentStijn van Roessel, Eran van Veldhuisen, Sjors Klompmaker, et al.
JAMA Oncology|January 23, 2025
Adjuvant Chemotherapy After Resection of Localized Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOXThomas F Stoop, Toshitaka Sugawara, Atsushi Oba, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 7, 2020
Development and external validation of a prediction model for survival in patients with resected ampullary adenocarcinomaAlma L Moekotte, Stijn van Roessel, Giuseppe Malleo, et al.
JAMA Network Open|June 18, 2024
Pathological Complete Response in Patients With Resected Pancreatic Adenocarcinoma After Preoperative ChemotherapyThomas F Stoop, Atsushi Oba, Y H Andrew Wu, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 22, 2021
Preoperative misdiagnosis of pancreatic and periampullary cancer in patients undergoing pancreatoduodenectomy: A multicentre retrospective cohort studyStijn van Roessel, Eline C Soer, Lois A Daamen, et al.
Journal of Surgical Oncology|June 11, 2021
Predicting overall survival and resection in patients with locally advanced pancreatic cancer treated with FOLFIRINOX: Development and internal validation of two nomogramsLilly J H Brada, Marieke S Walma, Lois A Daamen, et al.
The British Journal of Surgery|November 18, 2021
Venous wedge and segment resection during pancreatoduodenectomy for pancreatic cancer: impact on short- and long-term outcomes in a nationwide cohort analysisJesse V Groen, Nynke Michiels, Stijn van Roessel, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 12, 2020
Amsterdam International Consensus Meeting: tumor response scoring in the pathology assessment of resected pancreatic cancer after neoadjuvant therapyBoris V Janssen, Faik Tutucu, Stijn van Roessel, et al.
The British Journal of Surgery|July 13, 2023
Predictive value of baseline serum carbohydrate antigen 19-9 level on treatment effect of neoadjuvant chemoradiotherapy in patients with resectable and borderline resectable pancreatic cancer in two randomized trialsDeesje Doppenberg, Jacob L van Dam, Youngmin Han, et al.
Annals of Surgery|January 31, 2025
Validation of the PANAMA Score for Survival and Benefit of Adjuvant Therapy in Patients With Resected Pancreatic Cancer after Neoadjuvant FOLFIRINOXIngmar F Rompen, Thomas F Stoop, Stijn van Roessel, et al.
JAMA Oncology|September 10, 2020
Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX TreatmentStijn van Roessel, Eran van Veldhuisen, Sjors Klompmaker, et al.
JAMA Oncology|January 23, 2025
Adjuvant Chemotherapy After Resection of Localized Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOXThomas F Stoop, Toshitaka Sugawara, Atsushi Oba, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 7, 2020
Development and external validation of a prediction model for survival in patients with resected ampullary adenocarcinomaAlma L Moekotte, Stijn van Roessel, Giuseppe Malleo, et al.
JAMA Network Open|June 18, 2024
Pathological Complete Response in Patients With Resected Pancreatic Adenocarcinoma After Preoperative ChemotherapyThomas F Stoop, Atsushi Oba, Y H Andrew Wu, et al.
Pageof 3